Risks To Shareholder Returns Are Elevated At These Prices For Pharma Mar, S.A. (BME:PHM)
Aug 03
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedAug 15, 2025
DataAggregated Company Financials
Companies12
- 7D1.6%
- 3M18.8%
- 1Y25.2%
- YTD18.4%
In the last week, the Healthcare industry is up 1.6%, with Almirall up 9.6%. In the last 12 months, the industry was up 25%. Looking forward, earnings are forecast to grow by 28% annually.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 16 Aug 2025 | €17.4b | €11.1b | €610.7m | 25.3x | 28.5x | 1.6x |
| Mon, 14 Jul 2025 | €16.8b | €11.0b | €507.4m | 21.4x | 33.1x | 1.5x |
| Wed, 11 Jun 2025 | €16.3b | €11.0b | €507.4m | 22.4x | 32.1x | 1.5x |
| Fri, 09 May 2025 | €14.1b | €10.8b | €451.3m | 22.9x | 31.2x | 1.3x |
| Sun, 06 Apr 2025 | €13.5b | €10.8b | €458.2m | 19.3x | 29.4x | 1.2x |
| Tue, 04 Mar 2025 | €15.9b | €10.8b | €455.7m | 20.5x | 34.9x | 1.5x |
| Thu, 30 Jan 2025 | €14.7b | €10.6b | €392.4m | 20.1x | 37.3x | 1.4x |
| Sat, 28 Dec 2024 | €14.4b | €10.6b | €392.5m | 19.2x | 36.8x | 1.4x |
| Mon, 25 Nov 2024 | €15.4b | €10.5b | €393.8m | 19.5x | 39.1x | 1.5x |
| Wed, 23 Oct 2024 | €16.2b | €10.2b | €394.8m | 15.7x | 40.9x | 1.6x |
| Fri, 20 Sep 2024 | €15.3b | €10.2b | €399.9m | 15x | 38.3x | 1.5x |
| Sun, 18 Aug 2024 | €14.0b | €10.2b | €399.9m | 15.2x | 35.1x | 1.4x |
| Tue, 16 Jul 2024 | €15.3b | €10.0b | €405.9m | 19.8x | 37.7x | 1.5x |
| Thu, 13 Jun 2024 | €15.3b | €10.0b | €405.9m | 20.9x | 37.6x | 1.5x |
| Sat, 11 May 2024 | €14.9b | €10.0b | €266.6m | 18.5x | 55.8x | 1.5x |
| Mon, 08 Apr 2024 | €14.1b | €10.0b | €292.0m | 21.2x | 48.4x | 1.4x |
| Wed, 06 Mar 2024 | €13.0b | €10.0b | €289.0m | 20.9x | 45.1x | 1.3x |
| Fri, 02 Feb 2024 | €14.1b | €10.0b | €331.9m | 17.6x | 42.5x | 1.4x |
| Sun, 31 Dec 2023 | €17.2b | €10.0b | €332.6m | 17.3x | 51.6x | 1.7x |
| Tue, 28 Nov 2023 | €15.5b | €10.0b | €332.5m | 17.2x | 46.5x | 1.6x |
| Thu, 26 Oct 2023 | €13.2b | €9.8b | €302.1m | 16.9x | 43.7x | 1.3x |
| Sat, 23 Sep 2023 | €15.1b | €9.8b | €311.0m | 19.2x | 48.5x | 1.5x |
| Mon, 21 Aug 2023 | €15.4b | €9.8b | €311.0m | 19.8x | 49.5x | 1.6x |
| Wed, 19 Jul 2023 | €14.3b | €9.6b | €364.7m | 20.7x | 39.2x | 1.5x |
| Fri, 16 Jun 2023 | €13.5b | €9.6b | €364.6m | 20.8x | 36.9x | 1.4x |
| Sun, 14 May 2023 | €13.5b | €9.3b | €533.7m | 21.1x | 25.4x | 1.5x |
| Tue, 11 Apr 2023 | €12.4b | €9.3b | €563.7m | 18.9x | 22.1x | 1.3x |
| Thu, 09 Mar 2023 | €13.5b | €9.3b | €564.2m | 20x | 23.8x | 1.4x |
| Sat, 04 Feb 2023 | €15.5b | €8.4b | €430.6m | 13.8x | 36x | 1.9x |
| Mon, 02 Jan 2023 | €13.7b | €8.4b | €430.6m | 13.7x | 31.8x | 1.6x |
| Wed, 30 Nov 2022 | €13.5b | €8.4b | €431.4m | 14.4x | 31.2x | 1.6x |
| Fri, 28 Oct 2022 | €12.7b | €8.4b | €462.3m | 13.4x | 27.4x | 1.5x |
| Sun, 25 Sep 2022 | €13.4b | €8.3b | €461.7m | 13.7x | 29.1x | 1.6x |
| Tue, 23 Aug 2022 | €16.1b | €8.3b | €465.4m | 14.6x | 34.6x | 1.9x |
Price to Earnings Ratio
34.6x
Current Industry PE
- Investors are pessimistic on the Spanish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 28.5x which is lower than its 3-year average PE of 37.1x.
- The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 9.5% per year over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 3.07% | |
| Healthcare | 1.61% | |
| Pharma | 5.59% | |
| Healthcare Services | 0.89% | |
| Medical Equipment | 0.84% | |
| Life Sciences | 0% | 0 |
| Biotech | -1.01% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 40.1x.
- Analysts are expecting annual earnings growth of 115.7%, which is higher than its past year's earnings growth of 1.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 116% over the next 5 years.
- This is better than its past earnings growth rate of 1.7% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 23% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALM Almirall | €11.10 | 7.8% +€171.8m | 25.9% | PE111.7x | |
| ROVI Laboratorios Farmaceuticos Rovi | €56.40 | 4.9% +€135.5m | -26.0% | PE21.8x | |
| PHM Pharma Mar | €82.70 | 4.6% +€63.3m | 124.9% | PE34.6x | |
| CBAV Clínica Baviera | €44.00 | 0.2% +€1.6m | 48.1% | PE18.3x | |
| ATRY Atrys Health | €2.82 | 0.7% +€1.5m | -11.9% | PS1x |
